Brookfield Infrastructure Finance Ulc (BIPH)

$18.87

+0.05

(+0.27%)

Market is closed - opens 7 PM, 09 Sep 2024

Performance

  • $18.72
    $18.94
    $18.87
    downward going graph

    0.78%

    Downside

    Day's Volatility :1.15%

    Upside

    0.37%

    downward going graph
  • $14.60
    $19.62
    $18.87
    downward going graph

    22.63%

    Downside

    52 Weeks Volatility :25.59%

    Upside

    3.82%

    downward going graph

Returns

PeriodBrookfield Infrastructure Finance UlcIndex (Russel 2000)
3 Months
5.83%
0.0%
6 Months
-1.82%
0.0%
1 Year
12.72%
0.0%
3 Years
-27.78%
-22.3%

Highlights

Market Capitalization
357.5K
Book Value
$0.01
Earnings Per Share (EPS)
-0.09
PEG Ratio
0.0
Profit Margin
0.0%
Operating Margin TTM
-547.85%
Return On Assets TTM
-15.02%
Return On Equity TTM
0.0%
Revenue TTM
677.9K
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
17.1%
Gross Profit TTM
-332.4K
EBITDA
-2.9M
Diluted Eps TTM
-0.089
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY08Y/Y Change
Revenue
685.7K
↓ 30.71%
Net Income
-5.2M
↓ 70.78%
Net Profit Margin
-755.14%
↑ 1035.85%
FY09Y/Y Change
Revenue
677.9K
↓ 1.13%
Net Income
-17.1M
↑ 229.65%
Net Profit Margin
-2.5K%
↓ 1762.7%
FY21Y/Y Change
Revenue
8.9B
↑ 1310513.09%
Net Income
121.0M
↓ 808.88%
Net Profit Margin
1.36%
↑ 2519.2%
FY22Y/Y Change
Revenue
11.5B
↑ 29.85%
Net Income
613.0M
↑ 406.61%
Net Profit Margin
5.31%
↑ 3.95%
FY23Y/Y Change
Revenue
14.4B
↑ 25.05%
Net Income
87.0M
↓ 85.81%
Net Profit Margin
0.6%
↓ 4.71%
FY24Y/Y Change
Revenue
17.9B
↑ 24.29%
Net Income
87.0M
↑ 0.0%
Net Profit Margin
0.49%
↓ 0.11%
Q4 FY08Q/Q Change
Revenue
122.1K
↑ 13.54%
Net Income
-11.8M
↑ 375.07%
Net Profit Margin
-9.7K%
↓ 7369.47%
Q1 FY09Q/Q Change
Revenue
226.7K
↑ 85.7%
Net Income
-509.2K
↓ 95.69%
Net Profit Margin
-224.65%
↑ 9459.2%
Q2 FY23Q/Q Change
Revenue
4.5B
↑ 1979534.52%
Net Income
13.0M
↓ 2653.06%
Net Profit Margin
0.29%
↑ 224.94%
Q3 FY23Q/Q Change
Revenue
5.0B
↑ 10.76%
Net Income
-68.0M
↓ 623.08%
Net Profit Margin
-1.37%
↓ 1.66%
Q4 FY23Q/Q Change
Revenue
5.2B
↑ 4.37%
Net Income
46.0M
↓ 167.65%
Net Profit Margin
0.89%
↑ 2.26%
Q1 FY24Q/Q Change
Revenue
5.1B
↓ 0.94%
Net Income
-48.0M
↓ 204.35%
Net Profit Margin
-0.93%
↓ 1.82%
FY08Y/Y Change
Total Assets
26.8M
↓ 7.14%
Total Liabilities
4.5M
↓ 76.25%
FY09Y/Y Change
Total Assets
4.1M
↓ 84.78%
Total Liabilities
2.7M
↓ 40.07%
FY21Y/Y Change
Total Assets
61.3B
↑ 1502206.45%
Total Liabilities
39.7B
↑ 1469144.16%
FY22Y/Y Change
Total Assets
74.0B
↑ 20.59%
Total Liabilities
47.6B
↑ 19.95%
FY23Y/Y Change
Total Assets
73.0B
↓ 1.34%
Total Liabilities
47.4B
↓ 0.33%
FY24Y/Y Change
Total Assets
100.8B
↑ 38.12%
Total Liabilities
66.8B
↑ 40.82%
Q4 FY08Q/Q Change
Total Assets
4.4M
↓ 80.88%
Total Liabilities
2.6M
↓ 40.77%
Q1 FY09Q/Q Change
Total Assets
4.1M
↓ 8.03%
Total Liabilities
2.7M
↑ 2.3%
Q2 FY23Q/Q Change
Total Assets
97.7B
↑ 2393998.06%
Total Liabilities
63.8B
↑ 2361775.38%
Q3 FY23Q/Q Change
Total Assets
100.8B
↑ 3.12%
Total Liabilities
66.8B
↑ 4.73%
Q4 FY23Q/Q Change
Total Assets
103.3B
↑ 2.46%
Total Liabilities
70.6B
↑ 5.79%
Q1 FY24Q/Q Change
Total Assets
100.9B
↓ 2.29%
Total Liabilities
70.8B
↑ 0.21%
FY08Y/Y Change
Operating Cash Flow
4.7M
↓ 148.14%
Investing Cash Flow
247.0K
↓ 166.85%
Financing Cash Flow
-407.7K
↓ 103.67%
FY09Y/Y Change
Operating Cash Flow
-3.4M
↓ 172.81%
Investing Cash Flow
91.8K
↓ 62.84%
Financing Cash Flow
-2.3M
↑ 457.27%
Q4 FY08Q/Q Change
Operating Cash Flow
-1.2M
↑ 16.32%
Investing Cash Flow
1.1K
↓ 98.84%
Financing Cash Flow
-2.2M
↑ 81366.74%
Q1 FY09Q/Q Change
Operating Cash Flow
24.4K
↓ 102.12%
Investing Cash Flow
1.1K
↑ 0.0%
Financing Cash Flow
-93.4K
↓ 95.7%

Technicals Summary

Sell

Neutral

Buy

Brookfield Infrastructure Finance Ulc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Brookfield Infrastructure Finance Ulc
Brookfield Infrastructure Finance Ulc
8.01%
-1.82%
12.72%
-27.78%
-25.71%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
5.02%
20.15%
58.74%
31.28%
184.98%
Resmed Inc.
Resmed Inc.
16.09%
27.14%
62.7%
-17.28%
81.24%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.02%
-2.08%
-12.88%
-9.76%
-9.75%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
1.18%
-17.93%
-26.4%
-35.64%
104.36%
Alcon Ag
Alcon Ag
3.83%
8.9%
15.02%
11.44%
61.54%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Brookfield Infrastructure Finance Ulc
Brookfield Infrastructure Finance Ulc
NA
NA
0.0
0.0
0.0
-0.15
NA
0.01
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
81.91
81.91
4.06
6.65
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
35.33
35.33
2.05
7.71
0.23
0.13
0.01
33.11
Becton, Dickinson And Company
Becton, Dickinson And Company
46.72
46.72
1.08
13.11
0.06
0.03
0.02
89.5
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.71
42.71
5.15
6.51
0.2
0.11
0.0
35.49
Alcon Ag
Alcon Ag
42.64
42.64
3.53
3.05
0.05
0.03
0.0
42.35
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Brookfield Infrastructure Finance Ulc
Brookfield Infrastructure Finance Ulc
NA
$357.5K
-25.71%
NA
0.0%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$169.4B
184.98%
81.91
27.65%
Resmed Inc.
Resmed Inc.
Buy
$36.0B
81.24%
35.33
21.79%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.4B
-9.75%
46.72
7.13%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$21.8B
104.36%
42.71
18.25%
Alcon Ag
Alcon Ag
Buy
$46.7B
61.54%
42.64
11.44%

Insights on Brookfield Infrastructure Finance Ulc

  • Vs RMD

    In the last 1 year, Resmed Inc. has given 62.7% return, outperforming this stock by 50.0%

  • Vs ISRG

    In the last 3 years, Brookfield Infrastructure Finance Ulc has experienced a drawdown of -27.8%, however Intuitive Surgical, Inc. resisted the overall trend and outperformed by 10.5%

Company Information

Organization
Brookfield Infrastructure Finance Ulc
Employees
2
CEO
Ms. Margaret V. Russell
Industry
Medical Specialties

FAQs